Cormedix Inc (CRMD) Stock Price, Quote & News

Company Profile

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was in...

Industry: Biotechnology

Sector: Healthcare

Phone: 908 517 9500

Website: cormedix.com

Address:

389 Interpace Pkwy, Suite 450, Parsippany, United States

Noname2022 Jun. 4 at 11:29 PM

$CRMD $ICUI $DVA $FMS Hidden gem from ACCP 2025. CorMedix tested DefenCath’s taurolidine alongside a chlorhexidine catheter cap and found no antagonism across 46 isolates, with additive activity observed in ~70%. All tested S. aureus, K. pneumoniae, and P. aeruginosa isolates showed additivity. Not every poster is about efficacy. Some are about removing barriers to adoption. This one appears to do exactly that. https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70148

1 · Reply

grutpeter Jun. 4 at 10:53 PM

$CRMD bgms up 133% today. Are we next on unexpected news.

0 · Reply

Noname2022 Jun. 4 at 8:26 PM

$CRMD MSLs still educating nursing staff, look at that turnout!

0 · Reply

Derek22us Jun. 4 at 7:58 PM

$CRMD Never let be said that your momma raised an ask price dropper.

0 · Reply

barlaw Jun. 4 at 7:51 PM

$CRMD Sorta funny, and a bit odd, that the company logo can play as a broken heart.🤔

2 · Reply

Derek22us Jun. 4 at 6:59 PM

$CRMD The stench of sheister scumbag scammers permeates the trading activity.

0 · Reply

Derek22us Jun. 4 at 5:28 PM

$CRMD Kepp the exit door clear, you don't want to block those 100 share ask dropping selling chitheads from exiting. They are collaborators with the scavengers.

1 · Reply

InvestinPeace Jun. 4 at 5:11 PM

$CRMD trash

0 · Reply

TSLA_S3XY Jun. 4 at 4:57 PM

$CRMD Slow rise to double digits. C'mon JoeB

0 · Reply

Derek22us Jun. 4 at 4:23 PM

$CRMD I see the dirty rotten 700 and 1100 bassturds trying to limit the upside. Own real voteable shares in a cash account and keep your shares out of reach of the short turds. Margin users are toxic trash.

0 · Reply

CorMedix Transcript: Jefferies Global Healthcare Conference 2026

May 22, 2026, 7:00 AM EDT - 13 days ago

CorMedix Slides: Corporate presentation

May 20, 2026, 11:00 AM EDT - 15 days ago

CorMedix Transcript: RBC Capital Markets Global Healthcare Conference 2026

May 15, 2026, 8:30 AM EDT - 20 days ago

Cormedix Therapeutics to Participate in two Upcoming Investor Conferences

May 14, 2026, 8:30 AM EDT - 21 days ago

CorMedix Earnings Call Transcript: Q1 2026

May 14, 2026, 8:30 AM EDT - 21 days ago

CorMedix Earnings release: Q1 2026

May 14, 2026, 8:30 AM EDT - 21 days ago

CorMedix Quarterly report: Q1 2026

2026-05-14T11:53:51.000Z - 21 days ago

CorMedix reports Q1 EPS 43c, consensus 33c

2026-05-14T11:47:54.000Z - 21 days ago

CorMedix raises FY26 revenue view to $325M-$345M from $300M-$320M

May 14, 2026, 7:30 AM EDT - 21 days ago

Cormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

May 5, 2026, 8:30 AM EDT - 4 weeks ago

CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026

Apr 29, 2026, 8:00 AM EDT - 5 weeks ago

CorMedix Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 5 weeks ago

CorMedix Proxy statement: Proxy filing

2026-04-28T19:40:19.000Z - 5 weeks ago

Citizens healthcare analysts hold an analyst/industry conference call

2026-04-28T11:56:23.000Z - 5 weeks ago

CorMedix price target raised to $14 from $13 at RBC Capital

2026-04-27T12:05:37.000Z - 5 weeks ago

CorMedix announces ReSPECT clinical trial met primary endpoint

Apr 27, 2026, 7:30 AM EDT - 5 weeks ago

CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients

Apr 17, 2026, 8:00 AM EDT - 6 weeks ago

CorMedix Proxy statement: Proxy filing

Apr 14, 2026, 3:00 PM EDT - 7 weeks ago

CorMedix Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 7, 2026, 8:30 AM EDT - 2 months ago

CorMedix to Participate in Needham Virtual Healthcare Conference

Mar 11, 2026, 9:35 AM EDT - 3 months ago

CorMedix Transcript: The Citizens Life Sciences Conference 2026

Mar 10, 2026, 1:00 PM EDT - 3 months ago

CorMedix Transcript: Leerink Global Healthcare Conference 2026

Mar 7, 2026, 6:00 AM EST - 3 months ago

CorMedix Slides: Corporate presentation

2026-03-06T22:20:58.000Z - 3 months ago

CorMedix affirms FY26 revenue view of $300M-$320M, consensus $308.7M

2026-03-06T17:05:52.000Z - 3 months ago

CorMedix price target lowered to $13 from $15 at Leerink

Mar 5, 2026, 12:58 PM EST - 3 months ago

CorMedix stock drops after earnings: is this dip a buy before key catalyst?

Mar 5, 2026, 8:30 AM EST - 3 months ago

CorMedix Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 3 months ago

CorMedix Annual report: Q4 2025

Mar 5, 2026, 8:30 AM EST - 3 months ago

CorMedix Earnings release: Q4 2025

2026-03-05T12:36:24.000Z - 3 months ago

CorMedix reports Q4 EPS 16c vs 20c last year

Mar 5, 2026, 7:30 AM EST - 3 months ago

CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Mar 2, 2026, 8:30 AM EST - 3 months ago

CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026

Feb 12, 2026, 8:30 AM EST - 4 months ago

CorMedix to Participate in Upcoming Investor Conferences

Feb 10, 2026, 1:00 PM EST - 4 months ago

CorMedix Transcript: Investor Day 2026

Feb 10, 2026, 1:00 PM EST - 4 months ago

CorMedix Slides: FY 2026

2026-02-02T13:35:15.000Z - 4 months ago

CorMedix board authorizes share repurchase program of up to $75M

Feb 2, 2026, 8:30 AM EST - 4 months ago

CorMedix Therapeutics Announces Share Repurchase Program

Jan 29, 2026, 8:30 AM EST - 4 months ago

CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026

2026-01-23T11:10:42.000Z - 4 months ago

CorMedix price target lowered to $13 from $18 at H.C. Wainwright

2026-01-21T11:35:46.000Z - 4 months ago

CorMedix price target lowered to $13 from $22 at RBC Capital

Jan 12, 2026, 7:30 PM EST - 5 months ago

CorMedix Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 10, 2026, 7:00 AM EST - 5 months ago

CorMedix Slides: Corporate presentation

Jan 9, 2026, 8:30 AM EST - 5 months ago

CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Jan 8, 2026, 1:37 PM EST - 5 months ago

Why is CorMedix stock crashing today: is it worth buying on the dip?

2026-01-08T17:45:22.000Z - 5 months ago

CorMedix price target lowered to $16 from $20 at Truist

2026-01-08T13:17:12.000Z - 5 months ago

CorMedix sees FY26 revenue $300M-$320M

2026-01-08T13:17:02.000Z - 5 months ago

CorMedix CEO Joseph Todisco signs extended employment contract

Jan 8, 2026, 8:05 AM EST - 5 months ago

CorMedix Therapeutics Announces Leadership and Board Updates

Jan 8, 2026, 8:00 AM EST - 5 months ago

CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates

Dec 18, 2025, 8:00 AM EST - 6 months ago

CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath

Nov 12, 2025, 4:05 PM EST - 7 months ago

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

TLPH

Nov 12, 2025, 8:30 AM EST - 7 months ago

CorMedix Earnings Call Transcript: Q3 2025

Nov 12, 2025, 8:30 AM EST - 7 months ago

CorMedix Quarterly report: Q3 2025

Nov 12, 2025, 8:30 AM EST - 7 months ago

CorMedix Earnings release: Q3 2025

Nov 12, 2025, 7:30 AM EST - 7 months ago

CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance

Oct 31, 2025, 8:30 AM EDT - 7 months ago

CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025

Oct 24, 2025, 8:00 AM EDT - 7 months ago

CorMedix Proxy statement: Proxy Filing

Oct 23, 2025, 8:30 AM EDT - 8 months ago

CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath

Oct 22, 2025, 4:05 PM EDT - 8 months ago

Halper Sadeh LLC Encourages CorMedix Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 20, 2025, 9:42 AM EDT - 8 months ago

CRMD, RANI, CELC, RAPT: four biotech stocks flying high today and why

CELC RANI RAPT

Oct 20, 2025, 7:30 AM EDT - 8 months ago

CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance

Oct 14, 2025, 8:00 AM EDT - 8 months ago

CorMedix Proxy statement: Proxy Filing

Sep 30, 2025, 8:00 AM EDT - 8 months ago

CorMedix Registration statement: Registration Filing

Sep 29, 2025, 8:30 AM EDT - 8 months ago

CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO

Sep 15, 2025, 8:00 AM EDT - 9 months ago

CorMedix Proxy statement: Proxy Filing

Sep 10, 2025, 10:45 AM EDT - 9 months ago

CorMedix Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 8, 2025, 8:30 AM EDT - 9 months ago

CorMedix Announces Strategic Minority Investment in Talphera

TLPH

Sep 8, 2025, 8:30 AM EDT - 9 months ago

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

TLPH

Sep 5, 2025, 8:35 AM EDT - 9 months ago

CorMedix Transcript: Cantor Global Healthcare Conference 2025

Sep 2, 2025, 7:30 AM EDT - 9 months ago

CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team

Aug 7, 2025, 10:49 AM EDT - 10 months ago

CorMedix to Buy Melinta Therapeutics for $300 Million

Aug 7, 2025, 7:30 AM EDT - 10 months ago

CorMedix Quarterly report: Q2 2025

Aug 7, 2025, 7:30 AM EDT - 10 months ago

CorMedix Earnings release: Q2 2025

Aug 7, 2025, 7:10 AM EDT - 10 months ago

Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership

Aug 7, 2025, 7:00 AM EDT - 10 months ago

CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings

Aug 7, 2025, 7:00 AM EDT - 10 months ago

Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

Jun 27, 2025, 8:00 AM EDT - 1 year ago

CorMedix Inc. Announces Pricing of Public Offering of Common Stock

Jun 26, 2025, 4:01 PM EDT - 1 year ago

CorMedix Inc. Announces Proposed Public Offering of Common Stock

Jun 23, 2025, 7:30 AM EDT - 1 year ago

CorMedix inc. Announces Customer Implementation

Jun 5, 2025, 3:45 PM EDT - 1 year ago

CorMedix Transcript: Jefferies Global Healthcare Conference 2025

May 30, 2025, 8:30 AM EDT - 1 year ago

CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference

May 21, 2025, 3:05 PM EDT - 1 year ago

CorMedix Transcript: RBC Capital Markets Global Healthcare Conference 2025

May 15, 2025, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Participate in the RBC Global Healthcare Conference

May 8, 2025, 11:00 AM EDT - 1 year ago

CorMedix Transcript: The Citizens JMP Life Sciences Conference 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

CorMedix Earnings Call Transcript: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

CorMedix Quarterly report: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

CorMedix Earnings release: Q1 2025

May 6, 2025, 7:30 AM EDT - 1 year ago

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

Apr 29, 2025, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025

Apr 28, 2025, 8:00 AM EDT - 1 year ago

CorMedix Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

CorMedix Proxy statement: Proxy Filing

Apr 8, 2025, 2:15 PM EDT - 1 year ago

CorMedix Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 8, 2025, 7:30 AM EDT - 1 year ago

Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

Apr 2, 2025, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 25, 2025, 8:30 AM EDT - 1 year ago

CorMedix Earnings Call Transcript: Q4 2024

Mar 25, 2025, 8:30 AM EDT - 1 year ago

CorMedix Annual report: Q4 2024

Mar 25, 2025, 8:30 AM EDT - 1 year ago

CorMedix Earnings release: Q4 2024

Mar 25, 2025, 7:30 AM EDT - 1 year ago

CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Noname2022 Jun. 4 at 11:29 PM

1 · Reply

grutpeter Jun. 4 at 10:53 PM

$CRMD bgms up 133% today. Are we next on unexpected news.

0 · Reply

Noname2022 Jun. 4 at 8:26 PM

$CRMD MSLs still educating nursing staff, look at that turnout!

0 · Reply

Derek22us Jun. 4 at 7:58 PM

$CRMD Never let be said that your momma raised an ask price dropper.

0 · Reply

barlaw Jun. 4 at 7:51 PM

$CRMD Sorta funny, and a bit odd, that the company logo can play as a broken heart.🤔

2 · Reply

Derek22us Jun. 4 at 6:59 PM

$CRMD The stench of sheister scumbag scammers permeates the trading activity.

0 · Reply

Derek22us Jun. 4 at 5:28 PM

$CRMD Kepp the exit door clear, you don't want to block those 100 share ask dropping selling chitheads from exiting. They are collaborators with the scavengers.

1 · Reply

InvestinPeace Jun. 4 at 5:11 PM

$CRMD trash

0 · Reply

TSLA_S3XY Jun. 4 at 4:57 PM

$CRMD Slow rise to double digits. C'mon JoeB

0 · Reply

Derek22us Jun. 4 at 4:23 PM

0 · Reply

ReturnOfEsquire Jun. 4 at 3:46 PM

$CRMD The only possible negative catalyst is the acquisition of Talphera. That would likely damage the short-term value but add long-term benefit.

2 · Reply

drew64 Jun. 4 at 3:46 PM

$CRMD Trying to keep the lid on this is getting harder by the day🍻🤙🏼😎

0 · Reply

cosmogo Jun. 4 at 3:31 PM

$CRMD still here and loaded at lower levels as usual. Giddy up!

0 · Reply

golfguy42360 Jun. 4 at 3:30 PM

$CRMD Got 20 grand of this in my cash account at a cost basis of 8.70.Like the song says should I stay or should I go.

0 · Reply

Somebodyknowsomething Jun. 4 at 3:25 PM

$CRMD double digit, please

0 · Reply

TSLA_S3XY Jun. 4 at 3:24 PM

$CRMD Squeezey Squeezy

0 · Reply

REZZAYO Jun. 4 at 3:21 PM

$CRMD Finally after 1 year of pressuring it breaks out Target : $17-$19

1 · Reply

REZZAYO Jun. 4 at 2:09 PM

$CRMD Nasdaq bleeding $QQQ Health Care Booming $XLV $IBB $XBI Probably a Rotation

0 · Reply

tballgame Jun. 4 at 1:57 PM

$CRMD how about one of those 10% days? For old times sake

1 · Reply

Noname2022 Jun. 3 at 10:36 PM

$CRMD Re: TPN might be pushed earlier to 2027!

0 · Reply

Noname2022 Jun. 3 at 10:34 PM

$CRMD $AKBA $FMS $DVA Re: K-CAPA & June/July CMS update

0 · Reply

Noname2022 Jun. 3 at 10:32 PM

$TLPH $CRMD

2 · Reply

Market Cap	640.95M
Revenue (ttm)	311.71M
Net Income (ttm)	163.06M
EPS (ttm)	N/A
PE Ratio	4.47
Forward PE	18.11
Profit Margin	52.31%
Debt to Equity Ratio	0.00

Volume	1,445,800
Avg Vol	1,222,650
Day's Range	N/A - N/A
Shares Out	78.45M
Stochastic %K	89%
Beta	1.46
Analysts	Strong Sell
Price Target	$15.00